Indication

Congenital toxoplasmosis

Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy. Read more about Congenital toxoplasmosis

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Congenital toxoplasmosis therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Congenital toxoplasmosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Congenital toxoplasmosis.

Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy.

The parasite primarily damages the central nervous system, eyes, and reticuloendothelial system, causing pathology that ranges from asymptomatic subclinical infection to severe fetal morbidity or fetal demise.

Defining clinical features classically encompass the triad of chorioretinitis, hydrocephalus, and intracranial calcifications, frequently accompanied by microcephaly, seizures, sensorineural hearing loss, and systemic signs such as hepatosplenomegaly, jaundice, and thrombocytopenia.

While transmission risk rises in later gestation, maternal infections acquired earlier in pregnancy typically correlate with more severe fetal disease and long-term neurocognitive impairment.

Personalize your experience

Follow Congenital toxoplasmosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it